230 related articles for article (PubMed ID: 12733914)
21. Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin.
Zabala D; Song L; Dashti Y; Challis GL; Salas JA; Méndez C
Microb Cell Fact; 2020 May; 19(1):111. PubMed ID: 32448325
[TBL] [Abstract][Full Text] [Related]
22. Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis.
Pérez M; Baig I; Braña AF; Salas JA; Rohr J; Méndez C
Chembiochem; 2008 Sep; 9(14):2295-304. PubMed ID: 18756551
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of mithramycin biosynthesis in Streptomyces argillaceus: dual role as activator and repressor of the PadR-like regulator MtrY.
Flórez AB; Álvarez S; Zabala D; Braña AF; Salas JA; Méndez C
Microbiology (Reading); 2015 Feb; 161(Pt 2):272-284. PubMed ID: 25416691
[TBL] [Abstract][Full Text] [Related]
24. Semi-synthetic mithramycin SA derivatives with improved anticancer activity.
Scott D; Chen JM; Bae Y; Rohr J
Chem Biol Drug Des; 2013 May; 81(5):615-24. PubMed ID: 23331575
[TBL] [Abstract][Full Text] [Related]
25. The mithramycin gene cluster of Streptomyces argillaceus contains a positive regulatory gene and two repeated DNA sequences that are located at both ends of the cluster.
Lombó F; Braña AF; Méndez C; Salas JA
J Bacteriol; 1999 Jan; 181(2):642-7. PubMed ID: 9882681
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.
Previdi S; Malek A; Albertini V; Riva C; Capella C; Broggini M; Carbone GM; Rohr J; Catapano CV
Gynecol Oncol; 2010 Aug; 118(2):182-8. PubMed ID: 20452660
[TBL] [Abstract][Full Text] [Related]
27. An ABC transporter is essential for resistance to the antitumor agent mithramycin in the producer Streptomyces argillaceus.
Fernández E; Lombó F; Méndez C; Salas JA
Mol Gen Genet; 1996 Jul; 251(6):692-8. PubMed ID: 8757400
[TBL] [Abstract][Full Text] [Related]
28. Rationally designed glycosylated premithramycins: hybrid aromatic polyketides using genes from three different biosynthetic pathways.
Trefzer A; Blanco G; Remsing L; Künzel E; Rix U; Lipata F; Braña AF; Méndez C; Rohr J; Bechthold A; Salas JA
J Am Chem Soc; 2002 May; 124(21):6056-62. PubMed ID: 12022840
[TBL] [Abstract][Full Text] [Related]
29. Increased heterologous production of the antitumoral polyketide mithramycin A by engineered Streptomyces lividans TK24 strains.
Novakova R; Núñez LE; Homerova D; Knirschova R; Feckova L; Rezuchova B; Sevcikova B; Menéndez N; Morís F; Cortés J; Kormanec J
Appl Microbiol Biotechnol; 2018 Jan; 102(2):857-869. PubMed ID: 29196786
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer.
Malek A; Núñez LE; Magistri M; Brambilla L; Jovic S; Carbone GM; Morís F; Catapano CV
PLoS One; 2012; 7(4):e35130. PubMed ID: 22545098
[TBL] [Abstract][Full Text] [Related]
31. Structural insight into MtmC, a bifunctional ketoreductase-methyltransferase involved in the assembly of the mithramycin trisaccharide chain.
Chen JM; Hou C; Wang G; Tsodikov OV; Rohr J
Biochemistry; 2015 Apr; 54(15):2481-9. PubMed ID: 25587924
[TBL] [Abstract][Full Text] [Related]
32. Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationships.
Mansilla S; Garcia-Ferrer I; Méndez C; Salas JA; Portugal J
Biochem Pharmacol; 2010 May; 79(10):1418-27. PubMed ID: 20093108
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
Scott D; Rohr J; Bae Y
Int J Nanomedicine; 2011; 6():2757-67. PubMed ID: 22114504
[TBL] [Abstract][Full Text] [Related]
34. MtmMII-mediated C-methylation during biosynthesis of the antitumor drug mithramycin is essential for biological activity and DNA-drug interaction.
Rodríguez D; Quirós LM; Salas JA
J Biol Chem; 2004 Feb; 279(9):8149-58. PubMed ID: 14660589
[TBL] [Abstract][Full Text] [Related]
35. Premithramycinone G, an early shunt product of the mithramycin biosynthetic pathway accumulated upon inactivation of oxygenase MtmOII.
Abdelfattah MS; Rohr J
Angew Chem Int Ed Engl; 2006 Aug; 45(34):5685-9. PubMed ID: 16856198
[No Abstract] [Full Text] [Related]
36. Biosynthesis of the antitumor chromomycin A3 in Streptomyces griseus: analysis of the gene cluster and rational design of novel chromomycin analogs.
Menéndez N; Nur-e-Alam M; Braña AF; Rohr J; Salas JA; Méndez C
Chem Biol; 2004 Jan; 11(1):21-32. PubMed ID: 15112992
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of a monooxygenase involved in the biosynthetic pathway of the antitumor drug mithramycin.
Rodríguez D; Quirós LM; Braña AF; Salas JA
J Bacteriol; 2003 Jul; 185(13):3962-5. PubMed ID: 12813091
[TBL] [Abstract][Full Text] [Related]
38. The structure of mithramycin reinvestigated.
Wohlert SE; Künzel E; Machinek R; Méndez C; Salas JA; Rohr J
J Nat Prod; 1999 Jan; 62(1):119-21. PubMed ID: 9917296
[TBL] [Abstract][Full Text] [Related]
39. The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription.
Fernández-Guizán A; Mansilla S; Barceló F; Vizcaíno C; Núñez LE; Morís F; González S; Portugal J
Chem Biol Interact; 2014 Aug; 219():123-32. PubMed ID: 24907531
[TBL] [Abstract][Full Text] [Related]
40. The antitumor antibiotic mithramycin: new advanced approaches in modification and production.
Kormanec J; Novakova R; Csolleiova D; Feckova L; Rezuchova B; Sevcikova B; Homerova D
Appl Microbiol Biotechnol; 2020 Sep; 104(18):7701-7721. PubMed ID: 32686008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
